Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 319,832 | 56,857 | 67,209 |
| Marketable Securities | 31,024 | N/A | N/A |
| TOTAL | $355,923 | $59,804 | $68,444 |
| Non-Current Assets | |||
| PPE Net | 185 | 193 | 253 |
| Other Non-Current Assets | 13,860 | 8,183 | 5,882 |
| TOTAL | $14,045 | $8,376 | $6,135 |
| Total Assets | $369,968 | $68,180 | $74,579 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 17,136 | 5,396 | 5,815 |
| Accrued Expenses | 39,371 | 17,306 | 19,437 |
| TOTAL | $57,292 | $23,258 | $25,967 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 218 | 270,643 | 240,898 |
| TOTAL | $218 | $270,643 | $240,898 |
| Total Liabilities | $57,510 | $293,901 | $266,865 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 41,799 | N/A | N/A |
| Common Shares | 4 | N/A | N/A |
| Retained earnings | -387,391 | -230,403 | -193,279 |
| Other shareholders' equity | 194 | 37 | -41 |
| TOTAL | $312,458 | $-225,721 | $-192,286 |
| Total Liabilities And Equity | $369,968 | $68,180 | $74,579 |